Waters (WAT) Growth Rates Comparisons to Laboratory Analytical Instruments Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Customers, else..
 
Waters Corporation  (NYSE: WAT)
 

Waters Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

WAT Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) 120.91 % 10.93 % 10.18 % 10.9 %
Q / Q Revenue Growth (Q3 MRQ) 7.42 % -3.61 % -2.46 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 80.68 % 4.93 % 7.98 % %
Sequential Revenue Growth (for 12 months ending Q3 TTM) 20.82 % 2.55 % 2.1 % 2.61 %
Revenue 5 Year Average Growth 6 % 3.1 % 8.67 % 13.63 %


WAT's Growth Comparisons in III. Quarter 2026




Facing 120.91% year on year sales decrease in the third quarter 2026, to $ 1.77 billions, Waters reported smaller declines than the Laboratory Analytical Instruments industry with 10.93%, and less than 10.18% improvement in the Healthcare sector. Comparing the third quarter sales growth, both the Laboratory Analytical Instruments industry and Waters Corporation outperformed 10.9% overall market increase.

Comparing the company's Revenue to the second quarter results, sales were higher by 7.42% . On the yearly basis, average annual sales growth for Waters is 6%, while S & P 500's including only Businesses with the third quarter 2026 earnings, average annual sales growth is 13.63% over the past five years.

WAT Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Product
594.65 %
62.37 %
Service
187.74 %
56.34 %
Instrument Systems
-
63.54 %
Consumables
-
61.62 %
CN
-
62.95 %
Asia Other
353.9 %
60.77 %
Asia Pacific
-
61.75 %
US
-
63.15 %
Americas Other
610.73 %
60.95 %
Americas
-
62.76 %
European Union
-
56.92 %
Waters Analytical and Materials Sciences
-
55.13 %
Waters Biosciences
-
66 %
Waters Advanced Diagnostics
-
66.09 %
Member
-
60.65 %
Material Reconciling Items
-
60.65 %
Total
120.91 %
7.42 %


Growth Rates of WAT's Income in the third quarter 2026


WAT Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) -33.37 % 65.8 % 11.09 % 97.6 %
Sequential Operating Income Change (Q3 MRQ) - -28.55 % -12.21 % 48.13 %
Y / Y Operating Income Growth (Q3 TTM) -67.79 % 8.31 % 30.98 % 40.67 %
Sequential Operating Income Growth (Q3 TTM) -19.45 % 10.13 % 4.93 % 20.86 %
Operating Income 5 Year Avg. Change 4.45 % -6.57 % 10.27 % 18.8 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) -45.61 % - -38.86 % 90.69 %
Sequential Income from Cont. Ops. Change (Q3 MRQ) - - -63.27 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) -84.86 % - 9.88 % 57.33 %
Sequential Income from Cont. Ops. Change (Q3 TTM) -40.88 % -7.36 % -4.67 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change 4.26 % -16.43 % 8.91 % -28.64 %

WAT Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) -45.61 % -37.36 % -39.2 % 90.69 %
Q / Q Net Income Growth (Q3 MRQ) - -93.87 % 11.78 % 27.07 %
Y / Y Net Income Change (Q3 TTM) -84.81 % - 15.43 % 57.33 %
Sequential Net Income Change (Q3 TTM) -40.88 % -2.34 % -6.73 % 18.65 %
Net Income 5 Year Avg. Growth 4.26 % -16.48 % 9.09 % 23.95 %

WAT's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) -66.8 % - -38.86 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q3 MRQ) - - -63.27 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) -78.46 % - - -
Sequential EPS from Cont. Ops. Change (Q3 TTM) -41.54 % -56.32 % - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth 5.15 % -21.32 % 8.91 % -28.64 %



WAT EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) -67.2 % -38.53 % -39.2 % -28.64 %
Q / Q EPS Net Growth (Q3 MRQ) - -93.98 % 11.78 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q3 TTM) -41.9 % -56.29 % 10.63 % 4.93 %
EPS Net 5 Year Avg. Change 5.18 % -16.48 % 9.09 % 23.95 %



As Waters's income per share faded by -67.2% year on year in the third quarter, Laboratory Analytical Instruments industry fell only by -38.53%, Waters's third quarter performance was trailing Laboratory Analytical Instruments, and underperformed the -39.2% EPS slide in the Healthcare sector. Weak third quarter income per share, in Laboratory Analytical Instruments industry and within the Healthcare sector, were reflected in Waters Corporation results which underperformed overall market.

Comparing company's EPS to the second quarter results, income per share were higher by 7.42% . On the yearly basis, average annual income per share growth for Waters is 5.18%, while S & P 500's including only the businesses with the third quarter 2026 Results, average annual income per share growth is 23.95% over the past five years.

WAT Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) -66.64 % -38.71 % 44.26 % 48.62 %
Sequential Free Cash Flow Change (Q3 MRQ) -64.71 % -56.03 % -42.65 % 34.18 %
Y / Y Free Cash Flow Change (Q3 TTM) -75.3 % -16.71 % 19.33 % 60.27 %
Sequential Free Cash Flow Change (Q3 TTM) -27.07 % -7.54 % 5.88 % 15.75 %
Free Cash Flow 5 Year Avg. Change -2.57 % -2.7 % 0.41 % 1.8 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q3 MRQ) - - - 216.68 %
Y / Y Net Cash Flow Change (Q3 TTM) -95.7 % - - 209.43 %
Sequential Net Cash Flow Change (Q3 TTM) - -92.8 % - 152.64 %
Net Cash Flow 5 Year Avg. Change 21.05 % 16.21 % 6.46 % 1.07 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) 147.68 % -5.56 % 10.33 % 120.03 %
Sequential Capital Expenditures Change (Q3 MRQ) 31.25 % -18.49 % -19.32 % 36.87 %
Y / Y Capital Expenditures Change (Q3 TTM) 57.25 % -6.03 % 9.34 % 109.38 %
Sequential Capital Expenditures Change (Q3 TTM) 24.81 % -1.46 % 0.99 % 23.05 %
Capital Expenditures 5 Year Avg. Change -8.14 % 4.39 % 8.61 % 14.19 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.